Biology Methods & Protocols
GLP-1-based incretin therapy is associated with lower incident Alzheimer's disease and cardiorenal events in adults with documented neuropsychiatric, cognitive, or sensory risk
Cohort study of 153,412 peopleInterventions
- GLP-1 receptor agonists
- Semaglutide
- GLP-1 and incretin signalling
- Alzheimer's disease
- Acute kidney injury
- Humans
The paper
Nference (United States)
Biology Methods & Protocols, 3 Aug 2026
